Erkens JA - Search Results

1

Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study.

Erkens JA, Panneman MM, Klungel OH, van den Boom G, Prescott MF, Herings RM. Erkens JA, et al. Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):795-803. doi: 10.1002/pds.1156. Pharmacoepidemiol Drug Saf. 2005. PMID: 16178043

2

Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?

Spoelstra JA, Stolk RP, Heerdink ER, Klungel OH, Erkens JA, Leufkens HG, Grobbee DE. Spoelstra JA, et al. Among authors: erkens ja. Pharmacoepidemiol Drug Saf. 2003 Mar;12(2):121-7. doi: 10.1002/pds.760. Pharmacoepidemiol Drug Saf. 2003. PMID: 12642975

3

Increased suicide attempt rate among patients interrupting use of atypical antipsychotics.

Herings RM, Erkens JA. Herings RM, et al. Among authors: erkens ja. Pharmacoepidemiol Drug Saf. 2003 Jul-Aug;12(5):423-4. doi: 10.1002/pds.837. Pharmacoepidemiol Drug Saf. 2003. PMID: 12899119

4

Antihypertensive drug therapy and the risk of lower extremity amputations in pharmacologically treated type 2 diabetes patients.

Erkens JA, Klungel OH, Stolk RP, Spoelstra JA, Grobbee DE, Leufkens HG. Erkens JA, et al. Pharmacoepidemiol Drug Saf. 2004 Mar;13(3):139-46. doi: 10.1002/pds.932. Pharmacoepidemiol Drug Saf. 2004. PMID: 15072112

5

Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.

Penning-van Beest FJ, Goettsch WG, Erkens JA, Herings RM. Penning-van Beest FJ, et al. Among authors: erkens ja. Clin Ther. 2006 Feb;28(2):236-42. doi: 10.1016/j.clinthera.2006.01.002. Clin Ther. 2006. PMID: 16678644

6

Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal.

Sukel MP, van der Linden MW, Chen C, Erkens JA, Herings RM. Sukel MP, et al. Among authors: erkens ja. Pharmacoepidemiol Drug Saf. 2008 Jan;17(1):9-19. doi: 10.1002/pds.1508. Pharmacoepidemiol Drug Saf. 2008. PMID: 17963198

7

Incidence of cardiovascular events in breast cancer patients receiving chemotherapy in clinical practice.

Sukel MP, Breekveldt-Postma NS, Erkens JA, van der Linden PD, Beiderbeck AB, Coebergh JW, Herings RM. Sukel MP, et al. Among authors: erkens ja. Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):125-34. doi: 10.1002/pds.1528. Pharmacoepidemiol Drug Saf. 2008. PMID: 18058835

8

Treatment with inhaled corticosteroids in asthma is too often discontinued.

Breekveldt-Postma NS, Koerselman J, Erkens JA, van der Molen T, Lammers JW, Herings RM; CAMERA Study GroupMembers listed in the Appendix. Breekveldt-Postma NS, et al. Among authors: erkens ja. Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):411-22. doi: 10.1002/pds.1552. Pharmacoepidemiol Drug Saf. 2008. PMID: 18205251

9

Limited use of medicinal cannabis but for labeled indications after legalization.

Erkens JA, Janse AF, Herings RM. Erkens JA, et al. Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):821-2. doi: 10.1002/pds.1152. Pharmacoepidemiol Drug Saf. 2005. PMID: 16149121

10

Main comedications associated with major bleeding during anticoagulant therapy with coumarins.

Penning-van Beest F, Erkens J, Petersen KU, Koelz HR, Herings R. Penning-van Beest F, et al. Eur J Clin Pharmacol. 2005 Jul;61(5-6):439-44. doi: 10.1007/s00228-005-0947-0. Epub 2005 Jun 10. Eur J Clin Pharmacol. 2005. PMID: 15947920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters